Massimo Colombo
Impact in
- Hepatology top 0.02%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Liver physiology and pathology
- Liver Diseases and Immunity
- Epidemiology top 0.5%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 173
- Hepatitis C virus research 94
- Hepatocellular Carcinoma Treatment and Prognosis 62
- Liver Disease and Transplantation 15
- Liver physiology and pathology 11
- Liver Diseases and Immunity 11
- Epidemiology 83
- Hepatitis B Virus Studies 56
- Liver Disease Diagnosis and Treatment 27
- Co-authors
- Ersilio Del Ninno (19 shared papers)George C. Kuo (3 shared papers)Michael Houghton (3 shared papers)Q L Choo (2 shared papers)Angelo Sangiovanni (23 shared papers)Maria Francesca Donato (25 shared papers)Pietro Lampertico (45 shared papers)Ferruccio Bonino (3 shared papers)
- Journals
- Journal of Hepatology (38 papers)Digestive and Liver Disease (27 papers)Hepatology (18 papers)Gastroenterology (18 papers)Liver International (16 papers)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Massimo Colombo
241 papers receiving 16.1k citations
Massimo Colombo's Hit Papers
Peers
Comparison fields: 5 of 135
- Hepatology 11.3k
- Epidemiology 4.5k
- Hematology 375
- Biochemistry 130
- Cancer Research 230
Countries citing papers authored by Massimo Colombo
This map shows the geographic impact of Massimo Colombo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Colombo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Colombo more than expected).
Fields of papers citing papers by Massimo Colombo
This network shows the impact of papers produced by Massimo Colombo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Colombo. The network helps show where Massimo Colombo may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Colombo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 244 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis Hit paper breakdown → | 1989 | 2876 |
| 2 | Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030 Hit paper breakdown → | 2018 | 1538 |
| 3 | EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer Hit paper breakdown → | 2012 | 1355 |
| 4 | A proposed system for the nomenclature of hepatitis C viral genotypes Hit paper breakdown → | 1994 | 918 |
| 5 | Hepatocellular Carcinoma in Italian Patients with Cirrhosis Hit paper breakdown → | 1991 | 703 |
| 6 | PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA Hit paper breakdown → | 1989 | 598 |
| 7 | 2007 | 518 | |
| 8 | 2004 | 497 | |
| 9 | Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial Hit paper breakdown → | 2016 | 376 |
| 10 | 2010 | 319 | |
| 11 | 2003 | 299 | |
| 12 | 2008 | 261 | |
| 13 | 2010 | 221 | |
| 14 | 2011 | 200 | |
| 15 | 2013 | 192 | |
| 16 | 2003 | 182 | |
| 17 | 2016 | 174 | |
| 18 | 1985 | 166 | |
| 19 | 2009 | 165 | |
| 20 | 2013 | 157 |
About Massimo Colombo
Massimo Colombo is a scholar working on Hepatology, Epidemiology, Hematology, Genetics and Pathology and Forensic Medicine, having authored 244 papers that have together received 17k indexed citations. Recurring topics across this work include Hepatitis C virus research (94 papers), Hepatocellular Carcinoma Treatment and Prognosis (62 papers), Hepatitis B Virus Studies (56 papers), Liver Disease Diagnosis and Treatment (27 papers), Liver Disease and Transplantation (15 papers), Liver physiology and pathology (11 papers), Liver Diseases and Immunity (11 papers) and Hemophilia Treatment and Research (7 papers). The work is most often cited by research in Hepatology (11.3k citations), Epidemiology (4.5k citations), Hematology (375 citations), Biochemistry (130 citations) and Cancer Research (230 citations). Massimo Colombo has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Ersilio Del Ninno, George C. Kuo, Michael Houghton, Q L Choo, Angelo Sangiovanni, Maria Francesca Donato, Pietro Lampertico, Ferruccio Bonino, Maurizio Tommasini and Nicola Dioguardi. Their work appears in journals such as Journal of Hepatology, Digestive and Liver Disease, Hepatology, Gastroenterology and Liver International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.